SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : LIPO-Liposome
LIPO 0.330-5.7%10:56 AM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Rob-Chemist who wrote (500)9/27/1997 1:12:00 AM
From: Cacaito   of 900
 
American Journal of Perinatology, August/97 issue, there is a study from a group of clinicians and pharmacist (I do not remember authors institution), but they concocted a mixture of regular nutritional intravenous lipids (fats)with amphotericin B, for the sole purpose of finding a cheap alternative to the comercial liposome formulations, which they do considered to expensive. They have good results in decreasing toxicity. No emphasis in decreasing duration of treatment which remains an advantage of the comercial forms. Probably someone will find a way for that too. In poor countries the mixing will be a great alternative. They did show decent results. I do not know if this journal is in the web, but many medical libraries have it. I do not know how many US hospitals will try this, is not the US way, but in Europe will be a hit. This will bring more price pressure to the liposome companies if it become a significant trend.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News